Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMUB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,021
Award facts
- Contract value 100% obligated
- $41,020.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,020.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on June 5, 2025, with an ultimate completion date of June 27, 2025, represents a specific product draw-down from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The delivery order carries no set-aside designation, allowing the vendor to compete on its merits within the federal pharmaceutical procurement market.
DMS Pharmaceutical Group operates as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's extensive contract portfolio with DLA demonstrates its established capability to deliver specialized pharmaceutical products, including oncology treatments and injectable medications, to military health facilities nationwide. This particular delivery order for Keytruda, an oncology treatment, reflects the company's ongoing role in supporting the medical supply requirements of federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FNMUB?
SPE2DB25FNMUB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FNMUB worth?
The government has obligated $41,021 on SPE2DB25FNMUB.
Is contract SPE2DB25FNMUB an order under another contract?
Yes. SPE2DB25FNMUB is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMUB competed?
The extent of competition for SPE2DB25FNMUB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award